Cerulean Pharma (CERU) Worth Watching: Stock Soars 30.6% - Tale of the Tape

Comment

Shutterstock photo

Cerulean Pharma Inc. ( CERU ) was a big mover last session with its shares rising nearly 31% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend of the company as the stock has lost over 16% in the past one-month time frame.

This clinical-stage company developing nanopharmaceutical product candidates has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn't been in trend either. Yesterday's sharp climb is encouraging though, so make sure to keep a close watch on this firm in the near future.

Cerulean Pharma currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Investors interested in the Medical Drug industry may consider better-ranked stocks like Akorn Inc. ( AKRX ), Mallinckrodt plc ( MNK ) and KaloBios Pharmaceuticals, Inc. ( KBIO ). While Akorn and Mallinckrodt sport a Zacks Rank #1 (Strong Buy), KaloBios bears a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

CERULEAN PHARMA (CERU): Free Stock Analysis Report

AKORN INC (AKRX): Free Stock Analysis Report

MALLINCKRODT PL (MNK): Free Stock Analysis Report

KALOBIOS PHARMA (KBIO): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.



This article appears in: Investing , Investing Ideas , Stocks
Referenced Stocks: CERU , AKRX , MNK , KBIO


More from Zacks.com

Subscribe






Zacks.com
Contributor:

Zacks.com

Equity Research
Follow on:


Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com